Platelets: Biochemistry and physiology;Blutplättchen: Biochemie und Physiologie

Hamostaseologie

Volumn 23, Issue 4, 2003, Pages 149-158

  Kehrel, Beate E ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Platelet adhesion; Platelet aggregation; Platelet interaction with cells; Platelet procoagulant activity

Indexed keywords

ACETYLSALICYLIC ACID; RISTOCETIN; THROMBIN; THROMBOXANE RECEPTOR BLOCKING AGENT;

BLOOD CELL; BLOOD CLOT RETRACTION; CELL ACTIVITY; CHEMICAL ANALYSIS; CYTOSKELETON; HEMOSTASIS; HUMAN; PATHOPHYSIOLOGY; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; THROMBOCYTE RELEASE REACTION; THROMBOCYTE STRUCTURE;

EID: 0345307780     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619592     Document Type: Review

References (57)

1. Aszodi A, Pfeifer A, Ahmad M et al. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. EMBO J 1999; 18: 37-48.
2. Bevilacqua M, Butcher E, Furie B et al. Selectins: a family of adhesion receptors. Cell 67; 1991: 233.
3. Bouchard BA, Catcher CS, Thrash BR et al. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation. J Biol Chem 1999; 272: 9244-51.
4. Bouchard BA, Tracy PB. Platelets, leukocytes, and coagulation. Curr Opin Hematol 2001; 8: 263-9.
5. Brass LF, Hoxie JA, Manning DR. Signaling through G proteins and G protein-coupled receptors during platelet activation. Thromb Haemost 1993; 70: 217-23.
6. Brass LF, Pizarro S, Ahuja M et al. Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling. J Biol Chem 1994; 269: 2943-52.
7. Brass LF. More pieces of the platelet activation puzzle slide into place. J Clin Invest 1999; 104: 1663-5.
8. Clemetson JM, Polgar J, Magnenat E et al. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 1999; 274: 29019-24.
9. Clemetson KJ. Platelet activation: signal transduction via membrane receptors. Thromb Haemost 1995; 74: 111-6.
10. Clemetson KJ, Clemetson JM. Platelet GPIb-V-IX complex. Structure, function, physiology, and pathology. Semin Thromb Hemost 1995; 21: 130-6.
11. Clemetson KJ, Clemetson JM. Platelet collagen receptors. Thromb Haemost 2001; 86: 189-97.
12. Coller BS. Platelets and thrombolytic therapy. N Engl J Med 1990; 322: 33-42.
13. Coller BS. Antiplatelet agents in the prevention and therapy of thrombosis. Ann Rev Med 1992; 43: 171-80.
14. Coller BS. GPIIb/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab. Thromb Haemost 1997; 78: 730-5.
15. Dale GL, Friese P, Batar P et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002; 415: 175-9.
16. Dörmann D, Kardoeus J, Zimmermann RE et al. Flowcytometric analysis of agonist-induced annexin V, factor Va and factor Xa binding to human platelets. Platelets 1998; 9: 171-7
17. Dormann D, Clemetson KJ, Kehrel BE. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood 2000; 96: 2469-78.
18. Fox JE. The platelet cytoskeleton. Thromb Haemost 1993; 70: 884-93.
19. Frenette PS, Denis CV, Weiss L et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 2000; 191: 1413-22.
20. Fumeron F, Betoulle D, Nicaud V et al. Serotonin transporter gene polymorphism and myocardial infarction: Etude Cas-Temoins de l'Infarctus du Myocarde (ECTIM). Circulation 2002; 105: 2943-5.
21. Furie B, Furie BC, Flaumenhaft R. A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 2001; 86: 214-21.
22. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001; 86: 222-32.
23. Gao J, Zoller KE, Ginsberg MH et al. Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3. EMBO J 1997; 16: 6414-25.
24. George JN, Shattil SJ: The clinical importance of acquired abnormalities of platelet function. N Engl J Med 1991; 324: 27-39.
25. Gewirtz AM, Poncz M. Megakaryocytopoiesis and platelet function. In: Hoffmann R, Benz EJJr, Shattil SJ et al. (Hrsg). Hematology, Basic Principles and Practice. New York: Churchill-Livingstone 1991, 1148-57.
26. Hoffman M, Monroe DM, Roberts HR. Platelet-dependent action of high-dose factor VIIa. Blood 2002; 100: 364-5.
27. Holme PA, Orvim U, Hamers MJ et al. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol 1997; 17: 646-53.
28. Kaushansky K, Drachman JG. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene 2002; 21: 3359-67.
29. Kehrel B, Balleisen L, Kokott R et al. Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder. Blood 1988; 71: 1074-8.
30. Kehrel B. Platelet-collagen interactions. Semin Thromb Hemost 1995; 21: 123-9.
31. Kehrel B, Flicker E, Wigbels B et al. Thrombospondin measured in whole blood - an indicator of platelet activation. Blood Coagul Fibrinol 1996; 7: 202-5.
32. Kehrel BE, Wierwille S, Clemetson KJ et al. Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood 1998; 91: 491-9.
33. Lahav J, Jurk K, Hess O et al. Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange. Blood 2002; 100: 2472-8.
34. Lüscher EF, Weber S. The formation of the haemostatic plug-a special case of platelet aggregation. An experiment and a survey of the literature. Thromb Haemost 1993; 70: 234-7.
35. Marcus AJ, Broekman MJ, Drosopoulos JH et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997; 99: 1351-60.
36. Morgenstern E, Kehrel BE, Matzdorff A et al. How do platelets aggregate? 45th Meeting of the GTH, 17.2.2001 Düsseldorf. Ann Hematol 2001; 80: A48.
37. Morgenstern E. Morphologie der Thrombozyten. In: Müller-Berghaus G, Pötzsch B (Hrsg). Hämostaseologie. Berlin, Heidelberg, New York: Springer 1999, 1-14.
38. Monroe DM, Hoffman M, Oliver JA et al. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 1997; 99: 542-7.
39. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002; 22: 1381-9.
40. Nesheim ME, Furmaniak-Kazmierczak E, Henin C et al. On the existence of platelet receptors for factor V(a) and factor VIII(a). Thromb Haemost 1993; 70: 80-6.
41. Newman PJ. Switched at birth: a new family for PECAM-1. J Clin Invest 1999; 103: 5-9.
42. Newton-Nash DK, Newman PJ. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. J Immunol 1999; 163: 682-8.
43. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997; 96: 3534-41.
44. Oliver JA, Monroe DM, Roberts HR et al. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol 1999; 19: 170-7.
45. Phillips DR, Law D, Scarborough RM. Glycoprotein IIb-IIIa in platelet aggregation: an emerging target for the prevention of acute coronary thrombotic occlusions. Arch Pathol Lab Med 1998; 122: 811-2.
46. Polgar J, Clemetson JM, Kehrel BE et al. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J Biol Chem 1997; 272: 13576-83.
47. Rao AK. Congenital disorders of platelet function. Hematol Oncol Clin North Am 1990; 4: 65-86.
48. Rao AK. Congenital disorders of platelet function: disorders of signal transduction and secretion. Am J Med Sci 1998; 316: 69-76.
49. Rinder CS, Student LA, Bonan JL et al. Aspirin does not inhibit adenosine diphosphate-induced platelet alpha- granule release. Blood 1993; 82: 505-12.
50. Romo GM, Dong JF, Schade AJ et al. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P- selectin. J Exp Med 1999; 190: 803-14.
51. Ruggeri ZM. Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemost 1993; 70: 119-23.
52. Savage B, Shattil SJ, Ruggeri ZM. Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem 1992; 267: 11300-6.
53. Scandura JM, Walsh PN. Factor X bound to the surface of activated human platelets is preferentially activated by platelet-bound factor IXa. Biochemistry 1996; 35: 8903-13.
54. Schwarz UR, Walter U, Eigenthaler M. Taming platelets with cyclic nucleotides. Biochem Pharmacol 2001; 62: 1153-61.
55. Sims PJ, Wiedmer T, Esmon CT et al. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264: 17049-57.
56. Walter U, Eigenthaler M, Geiger J et al. Role of cyclic nucleotide-dependent protein kinases and their common substrate VASP in the regulation of human platelets. Adv Exp Med Biol 1993; 344: 237-49.
57. Wiedmer T, Shattil SJ, Cunningham M et al. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 1990; 29: 623-32.